Saturday - October 18, 2025
Breakthrough T1D Congratulates Civica on Launch of its First Low-Cost, Long-Acting Insulin
October 16, 2025
NEW YORK, Oct. 16 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:

* * *

Breakthrough T1D Congratulates Civica on Launch of its First Low-Cost, Long-Acting Insulin

*

Breakthrough T1D congratulates non-profit pharmaceutical company Civica on the launch of its first low-cost, long-acting insulin. Beginning Jan. 1, 2026, Civica insulin glargine in pre-filled pens wil . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products